Healthy Beginnings

Using the Body’s T-Cells to Fight Cancer

CD4 count

There has been lots of information in the news lately about “new” ways of using T-cells in the fight against cancer.

T-cells or T lymphocytes are cells that are made in the thymus gland right behind the sternum or breastbone. They are major players in the body’s defense against many viral diseases as well as cancer. These are the cells that can turn into “NK” or natural killer cells.

They are also some of the first cells to die during full dose chemotherapy.

T-cells can work with another type of very specific cells in the immune system called “dendritic cells” (some of you may have heard of “dendritic cell vaccine.”)

Dendritic cells were first described by Paul Langerhans in the nineteenth century. The term “dendritic cells” was first coined by Ralph Steinman and Zanvil Cohn. Steinman received the Nobel Prize in Medicine in 2011.

There are three types of dendritic cells that have been discovered in human blood. Once activated, they seek out T-cells to initiate and shape what is called the adaptive immune response.

Exosomes are packets or vesicles located in the cell membranes of dendritic cells. They contain specific proteins, one of which is called hsc73. This protein is called a “cytosolic heat shock protein” and it has been shown to induce a very potent antitumor immune response.

So, in practical terms, there is a way to stimulate a person’s own immune system to be able to start killing cancer cells in their system.

The first thing that must be present in a person who is trying to accomplish this is they must have a good strong immune system with enough T-lymphocytes and dendritic cells. This can be accomplished by the use of some specific herbal and mushroom supplements.

Then a blood sample is drawn and the tubes are spun in a centrifuge at a specific speed for a specific time. This separates the blood cells into layers so the T-cells and dendritic cells can be concentrated and removed.

Then the cells are incubated at a specific temperature overnight to stimulate them to start producing the “heat shock proteins.”

The next day, these cells are injected back into the patient’s muscle where they get into the blood and start to do their work against cancer.

This therapy may be new to these Universities but we have been doing it here in Reno for the past 5 years.

For further information contact Reno Integrative Medical Center, 6110 Plumas St., Ste.B, Reno, NV 89519, 775-829-1009, www.renointegrative.com

References:

Thery, Regnault, Garin, Wolfers, Zitvogel, Castagnoli, Raposo, Amigorena, Selective Accumulation of the Heat Shock Protein HSC73, The Journal of Cell Biology, November 1999, 147(3)599

Suto, Ryuichiro. Pramod, A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides, Science 269.5230 (Sep 15, 1995): 1585